Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Walter E, Uber"'
Autor:
Rosanne Rouf, Stuart D. Russell, Maureen Converse, Ryan J. Tedford, Walter E. Uber, Minoosh Sobhanian, Bhavadharini Ramu, Holly B. Meadows, George Mawardi, Rahatullah Muslem, Brian A. Houston, Tim M. Markman, Daniel P. Judge
Publikováno v:
Heart Lung and Circulation, 29(8), 1241-1246. Elsevier Ltd.
Background Gastrointestinal bleeding (GIB) is common in left ventricular assist device (LVAD) patients. Serotonin release from platelets promotes platelet aggregation, and selective serotonin reuptake inhibitor/serotonin-norepinephrine reuptake inhib
Publikováno v:
Open Access Surgery, Vol 2009, Iss default, Pp 15-34 (2009)
Brianne L Dunn1, Walter E Uber1, John S Ikonomidis21Department of Pharmacy Services and 2Division of Cardiothoracic Surgery, Medical University of South Carolina, Charleston, South Carolina, USAAbstract: Coagulopathic bleeding may lead to increased m
Externí odkaz:
https://doaj.org/article/815016cc443e4db0a7284c12c0a93be7
Publikováno v:
ASAIO Journal.
The relative efficacy of bridging with low-molecular-weight heparin (LMWH) or unfractionated heparin (UFH) in left ventricular assist device (LVAD) patients has not been established. We performed a retrospective, longitudinal cohort study to evaluate
Autor:
Johana Fajardo, Brian A. Houston, E.P. Morgan, Jaclyn M. Hawn, Holly B. Meadows, Walter E. Uber, Caroline Perez, Ryan J. Tedford, Lucian Lozonschi
Publikováno v:
The Journal of Heart and Lung Transplantation. 39:S93-S94
Purpose Aspirin (ASA) therapy is recommended in left ventricular assist device (LVAD) patients to prevent thromboembolic complications. Up to 30% of LVAD patients may demonstrate ASA resistance, which has been related to thrombotic complications. How
Autor:
Krista L. McElray, Sara Strout, Tara M Veasey, Jennifer L. Cook, John M. Toole, Holly B. Meadows, Adrian B. Van Bakel, Michael L. Craig, Catherine K. Floroff, Meredith A. Brisco-Bacik, Walter E. Uber
Publikováno v:
Artificial organs. 43(8)
Continuous-flow left ventricular assist device (LVAD) placement has become a standard of care in advanced heart failure treatment. Bleeding is the most frequently reported adverse event after LVAD implantation and may be increased by antithrombotic a
Autor:
Rupak Mukherjee, Alicia Sievert, John M. Toole, Walter E. Uber, Walter F. DeNino, Christopher B. Carter, Ashley Goss
Publikováno v:
Perfusion. 31:424-430
Objective: Dabigatran etexilate is a direct thrombin inhibitor approved for use in patients with non-valvular atrial fibrillation. There is no currently available pharmacological therapy to reverse this renally cleared anticoagulant. Dabigatran has a
Autor:
Brian A. Houston, Holly B. Meadows, M. Converse, Daniel P. Judge, Ryan J. Tedford, G. Mawardi, T. Markman, Walter E. Uber, Rahatullah Muslem, M. Sobhanian
Publikováno v:
The Journal of Heart and Lung Transplantation. 37:S160-S161
Autor:
Walter F. DeNino, Holly B. Meadows, John Lazarchick, Meredith A. Brisco-Bacik, Catherine K. Floroff, D. Heyward, Walter E. Uber, John M. Toole, Krista L. Rieger, Martha R. Stroud, Jennifer L. Cook, Sara E. Strout, Tara M. Veasey
Publikováno v:
ASAIO journal (American Society for Artificial Internal Organs : 1992). 63(5)
Pump thrombosis (PT) is a severe complication of left ventricular assist device (LVAD) support. This study evaluated PT and bleeding after LVAD placement in patients responsive to a standard aspirin dose of 81 mg using platelet inhibition monitoring
Autor:
Carol L. White, Tanna B. Cooper, David J. Taber, Walter E. Uber, Heather Kokko, Joseph E Mazur
Publikováno v:
American Journal of Health-System Pharmacy. 69:1993-1998
Purpose The impact of a collaborative drug therapy management (CDTM) agreement enabling pharmacist-managed direct thrombin inhibitor (DTI) therapy was evaluated. Methods A retrospective chart review was conducted to compare selected outcome measures
Autor:
Stacia M. DeSantis, A Lauren Haney, Francis G. Spinale, Andrew M. Atz, Rachael L. Deardorff, Eric M. Graham, Scott M. Bradley, Scott Reeves, Walter E. Uber, Jenna F Gillis, Francis X. McGowan
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 143:1069-1076
ObjectiveFactors contributing to postoperative complications include blood loss and a heightened inflammatory response. The objective of this study was to test the hypothesis that aprotinin would decrease perioperative blood product use, reduce bioma